Clozapine-related thromboembolism: 12 cases reported to SADRAC Clinical study 09 February 2013 Pages: 21 - 21
Ethinylestradiol/drospirenone [`Yasmin'; Schering AG] has been approved in its first market, News item 09 February 2013 Pages: 22 - 22
Rofecoxib [`Vioxx'] was associated with significantly fewer adverse gastrointestinal (GI) events Media release 09 February 2013 Pages: 22 - 22